US 8597883
Biomarkers for cancer-related fatigue and use thereof
granted A61PA61P35/00
Quick answer
US patent 8597883 (Biomarkers for cancer-related fatigue and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P35/00